TaiMed Biologics (ROCO:4147) ROE % Adjusted to Book Value : -0.69% (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics ROE % Adjusted to Book Value?

TaiMed Biologics's ROE % for the quarter that ended in Sep. 2024 was -3.63%. TaiMed Biologics's PB Ratio for the quarter that ended in Sep. 2024 was 5.25. TaiMed Biologics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -0.69%.

TaiMed Biologics ROE % Adjusted to Book Value Historical Data

The historical data trend for TaiMed Biologics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics ROE % Adjusted to Book Value Chart

TaiMed Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.16

-0.84

-2.45

-1.45

-0.91

TaiMed Biologics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-0.11	-1.14	-0.33	-0.45	-0.69

Competitive Comparison of TaiMed Biologics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, TaiMed Biologics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TaiMed Biologics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiMed Biologics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where TaiMed Biologics's ROE % Adjusted to Book Value falls into.

TaiMed Biologics ROE % Adjusted to Book Value Calculation

TaiMed Biologics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-7.38%	/	8.09
	=	-0.91%

TaiMed Biologics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-3.63%	/	5.25
	=	-0.69%

TaiMed Biologics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

http://www.taimedbiologics.com

TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others. It earns revenue from sale of medicines and by providing contract testing and development services for biopharmaceuticals.

TaiMed Biologics Headlines

No Headlines